Cardiometabolic Health

COVID-19 Resource Hub

Cardiometabolic Health

COVID-19 Resource Hub

Articles

AHA Library

Myocardial injury in adults hospitalized with COVID-19

Wiley Online Library

Sodium-glucose co-transporter-2 inhibitors and susceptibility to COVID-19: a population-based retrospective cohort study

NEJM Logo

Early elevation of FIB-4 liver fibrosis score is associated with adverse outcomes among patients with COVID-19

AHA Library

Drug-Induced arrhythmias: a scientific statement from the American Heart Association

Care Diabetes Journals

DPP-4 inhibitor sitagliptin can reduce mortality in T2DM patients with COVID-19

JACC Electrophysiology

Arrhythmias and COVID-19: a review

JACC Electrophysiology

Hydroxychloroquine/azithromycin therapy and QT prolongation in hospitalized patients with COVID-19

Care Diabetes Journals

Feasibility of inpatient CGM during the COVID-19 pandemic: early experience

ScienceDirect

SGLT2 inhibition during the COVID-19 epidemic: friend or foe?

NEJM Logo

Covid-19 and disparities in nutrition and obesity

Springer Link Logo

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

JAMA Network

Caring for older adults with diabetes during the COVID-19 pandemic

JACC Logo

Innovative transthoracic echocardiographic imaging on prone ventilated patients with COVID-19

JACC Logo

Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19

ScienceDirect

Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes

NEJM Logo

Diabetic ketoacidosis in COVID-19: unique concerns and considerations

ScienceDirect

COVID-19 presenting as Takotsubo cardiomyopathy complicated with atrial fibrillation

Springer Link Logo

Cardiovascular complications of COVID-19: pharmacotherapy perspective

NEJM Logo

The close relationship between COVID-19 and out-of-hospital cardiac arrests

Springer Link Logo

Hyperglycemia at admission can increase mortality risk in COVID-19 patients

National Center for Biotechnology Information

COVID-19 in people living with diabetes: an international consensus

National Center for Biotechnology Information

Cholesterol in relation to COVID-19: should we care about it?

Heart Rhythm

COVID-19 and cardiac arrhythmias

Care Diabetes Journals

COVID-19 in people with diabetes: urgently needed lessons from early reports

JAMA Network

Association of ACE inhibitor or ARB use with COVID-19 diagnosis and mortality

AHA Library

Approach to acute CV complications in COVID-19 infection

NEJM Logo

International registry of new-onset diabetes in COVID-19

Metabolism Journal

Severe obesity associated with higher in-hospital mortality in patients with COVID-19

Wiley Online Library

Exposure to DPP-4 inhibitors in patients with type 2 diabetes and COVID-19

NEJM Logo

A pragmatic approach to inpatient diabetes management during the COVID-19 pandemic

AHA Library

Cardiac manifestations of COVID-19 by echocardiography

Wiley Online Library

Hydroxychloroquine in patients with diabetes: risk and benefits in the setting of COVID-19

The Lancet

Obesity could shift severe COVID-19 disease to younger ages

NEJM Logo

Remdesivir for the treatment of COVID-19 - preliminary report

AHA Logo

No evidence to abandon RAAS inhibitors in COVID-19

NEJM Logo

Coronavirus infections and Type 2 Diabetes—shared pathways with therapeutic implications

NEJM Logo

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

NEJM Logo

Mild or Moderate Covid-19

NEJM Logo

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19

NEJM Logo

Collateral Effect of Covid-19 on Stroke Evaluation in the United States

JAMA Network

COVID-19 and Racial/Ethnic Disparities

The Lancet

Bariatric and metabolic surgery guidance in the era of COVID-19

BMJ Journal

Cardiovascular manifestations and treatment considerations in Covid-19

MAL Pub

Top 10 tips for successfully implementing a diabetes telehealth program

Sage Pub

Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States

NEJM Logo

Compassionate use of remdesivir for patients with severe Covid-19

The Lancet

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

FDA

Remdesivir Authorized for Emergency Use in COVID-19 by the FDA

Jama Network

Risk of QT Interval Prolongation Associated with Use of Hydroxychloroquine With or Without Azithromycin Among Hospitalized Patients Testing Positive for COVID-19

Jama Network

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for COVID-19

The Lancet

COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way

The Lancet

Practical recommendations for the management of diabetes in patients with COVID-19

Jama Network

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Jama Network

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

The Lancet

Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes

AHA Logo

The Variety of Cardiovascular Presentations of COVID-19

JACC Logo

The Restructuring of Structural Heart Disease Practice During the Covid-19 Pandemic

JACC Logo

ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak

Academic Logo

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

NEJM Logo

Mental Health and the Covid-19 Pandemic

NEJM Logo

Developing Covid-19 Vaccines at Pandemic Speed

Cell Logo

Ongoing Clinical Trials for the Management of the COVID-19 Pandemic

NEJM

Compassionate Use of Remdesivir for Patients with Severe Covid-19

National Center for Biotechnology Information

Are Patients With Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection?

National Center for Biotechnology Information

Our Response to COVID-19 as Endocrinologists and Diabetologists

NEJM

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

The Lancet

Virtual health care in the era of COVID-19

The Journal of Clinical Investigation

Convalescent Plasma for the Prevention and Treatment of COVID-19

AHA Journals

COVID-19 and the Heart

AHA Journals

Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment

ScienceDirect

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

Ajcp

This article discuss the emergence of coronaviruses in two decades.
Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19

SpringerLink

This review explores the clinical characteristics of COVID-19
Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)

The Lancet

The articles discuss the significance of social distancing interventions against COVID-19.
Scientific and ethical basis for social-distancing interventions against COVID-19

The Lancet

This Article reviews the treatment approaches for COVID-19
COVID-19: combining antiviral and anti-inflammatory treatments

Nature Reviews Cardiology

COVID-19 and the cardiovascular system

The Lancet

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Show More

Expert Perspectives

The impact of COVID-19 in patients with diabetes

The impact of COVID-19 in patients with diabetes

In this podcast, CMHC chair Dr. Anne Peters, Professor of Medicine and Director of Clinical Diabetes Programs at the University of Southern California in LA, discusses the impact of COVID-19 in patients with diabetes

Recorded March 25, 2020

Listen Now
The impact of COVID-19 in patients with diabetes

"COVID-19 and Cardiovascular Disease" with Clyde Yancy, MD

In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between CVD and COVID-19, including cardiac injury, RAASi therapy, and more.

Recorded April 1, 2020

Listen Now
The impact of COVID-19 in patients with diabetes

"COVID-19, cardiac injury, and statin therapy" with Christie Ballantyne, MD

In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.

Recorded March 25, 2020

Listen Now
The impact of COVID-19 in patients with diabetes

The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19

Listen to CMHC's Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEis and ARBs should be withdrawn in patients with COVID-19.

Recorded 3/26/2020

Listen Now

Resources for Clinicians

World Health Organization:

Centers for Disease Control and Prevention (CDC)

STATE-WISE

Other resources

Resources for Cardiometabolic Patients

Do The Five

Do the five

DOWNLOAD
Symptoms of Coronavirus

Symptoms of Coronavirus

DOWNLOAD
#Istayathome

#Istayathome

DOWNLOAD
What to do if you are sick

What to do if you are sick

DOWNLOAD

Blog

THE SILENT SUB-EPIDEMIC: THE RISING POPULATION OF PATIENTS FORGOING NEEDED MEDICAL CAREABLO

THE SILENT SUB-EPIDEMIC: THE RISING POPULATION OF PATIENTS FORGOING NEEDED MEDICAL CAREABLO

MAY 6, 2020

With the novel coronavirus (COVID-19) outbreak taking over hospitals across the country and globe, elective procedures postponed, and non-emergency visits cancelled, many hospital units and healthcare facilities have been entirely transformed into specialized COVID-19 units. Many others, however, have retained most of their previous...

Read More
THE IMPACT OF COVID-19 ON THE CARDIOMETABOLIC HEALTHCARE COMMUNITY

THE IMPACT OF COVID-19 ON THE CARDIOMETABOLIC HEALTHCARE COMMUNITY

APRIL 30, 2020

The COVID-19 pandemic has resulted in significant morbidity and mortality across the world, and the numbers continue to rise. Amid this pandemic, clinicians still have to diagnose, assess, and treat patients for both COVID-19 and non-COVID-19 medical issues. This extremely contagious disease has brought upon new realities and posed...

Read More
IMPLEMENTING TELEHEALTH INTO YOUR CARDIOLOGY PRACTICE

IMPLEMENTING TELEHEALTH INTO YOUR CARDIOLOGY PRACTICE

APRIL 4, 2020

In light of the novel coronavirus (COVID-19) outbreak many medical practices have been forced to conduct their business online via newly implemented or existing telehealth programs. Previously used as an adjunct to in-person care, telecardiology is set to replace the majority of outpatient cardiac clinic visits for the foreseeable future.

Read More
CHANGES TO CARDIOLOGY PRACTICES DURING THE COVID-19 OUTBREAK

CHANGES TO CARDIOLOGY PRACTICES DURING THE COVID-19 OUTBREAK

MARCH 26, 2020

Cardiologists and medical professionals across specialties are currently being faced with continuously evolving directives that aim to respond to developments in the novel coronavirus outbreak; they aim to minimize the risk of exposure, protect vulnerable demographics, and ensure the healthcare system can handle rapidly increasing demands.

Read More